We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-10.24%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$903M
AUM Growth
-$116M
Cap. Flow
-$11.6M
Cap. Flow %
-1.29%
Top 10 Hldgs %
46.73%
Holding
67
New
11
Increased
23
Reduced
18
Closed
12

Top Buys

Rank Stock Value
1
ACAD icon
Acadia Pharmaceuticals
ACAD
+$29.6M
2
BIIB icon
Biogen
BIIB
+$25.1M
3
COLL icon
Collegium Pharmaceutical
COLL
+$23.2M
4
AET
Aetna Inc
AET
+$21.8M
5
NUVA
NuVasive, Inc.
NUVA
+$20.5M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$45M
2
GILD icon
Gilead Sciences
GILD
+$41.5M
3
ALGN icon
Align Technology
ALGN
+$22.7M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$20.9M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$19M

Sector Composition

Rank Sector Weight
1 Healthcare 90.27%
2 Financials 2.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WMGI
26
DELISTED
Wright Medical Group Inc
WMGI
$10.5M 1.17%
458,977
-46,028
-9% -$1.07M
NDRM
27
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$9.79M 1.08%
440,799
+278,828
+172% +$5.22M
AERI
28
DELISTED
Aerie Pharmaceuticals
AERI
$8.91M 0.99%
235,298
-13,902
-6% -$526K
XLRN
29
DELISTED
Acceleron Pharma
XLRN
$8.81M 0.98%
345,225
-136,540
-28% -$4.33M
NVO
30
Novo Nordisk
NVO
$221B
$8.48M 0.94%
472,760
-417,990
-47% -$7.58M
ICPT
31
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$8.06M 0.89%
74,150
+3,499
+5% +$417K
EVHC
32
DELISTED
Envision Healthcare Holdings Inc
EVHC
$7.91M 0.88%
+125,040
New +$8.17M
MOH icon
33
Molina Healthcare
MOH
$12B
$7.42M 0.82%
136,845
-16,300
-11% -$892K
XENT
34
DELISTED
Intersect ENT, Inc
XENT
$6.47M 0.72%
534,937
+366,797
+218% +$4.75M
PRTA icon
35
Prothena Corp
PRTA
$451M
$6.08M 0.67%
123,646
-300
-0.2% -$16.6K
IART icon
36
Integra LifeSciences
IART
$1.49B
$5.94M 0.66%
138,400
– –
MNTA
37
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$5.71M 0.63%
379,500
+24,600
+7% +$325K
ADXS
38
DELISTED
Advaxis Inc
ADXS
$4.94M 0.55%
46,005
+16,894
+58% +$2.28M
SCAI
39
DELISTED
Surgical Care Affiliates, Inc.
SCAI
$4.55M 0.5%
98,300
– –
RARX
40
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$3.84M 0.43%
+252,940
New +$3.44M
INCY icon
41
Incyte
INCY
$23.1B
$3.45M 0.38%
34,374
-189,289
-85% -$18.5M
KTWO
42
DELISTED
K2M Group Holdings, Inc
KTWO
$3.12M 0.35%
+155,450
New +$2.95M
ENTL
43
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$2.48M 0.27%
130,496
-3,100
-2% -$59.5K
AGIO icon
44
Agios Pharmaceuticals
AGIO
$2.38B
$2.29M 0.25%
54,900
+2,200
+4% +$115K
RDY icon
45
Dr. Reddy's Laboratories
RDY
$10.5B
$1.46M 0.16%
160,775
– –
SAGE
46
DELISTED
Sage Therapeutics
SAGE
$1.43M 0.16%
+27,899
New +$1.32M
INSM icon
47
Insmed
INSM
$23.6B
$1.37M 0.15%
+103,300
New +$1.41M
DBVT
48
DBV Technologies
DBVT
$844M
$1.35M 0.15%
3,840
-90
-2% -$32.3K
PTCT icon
49
PTC Therapeutics
PTCT
$6.47B
$1.34M 0.15%
123,135
-656,863
-84% -$6.89M
AVXS
50
DELISTED
AveXis, Inc. Common Stock
AVXS
$1.11M 0.12%
23,215
-123,300
-84% -$6.59M
1
2
3

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $121M AUM 74.36% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
FWA
Fulcrum Wealth Advisors Bellevue, Washington $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM

Sectoral Asset Management's Q4 2016 Portfolio in Review

As of Q4 2016, Sectoral Asset Management held 67 positions worth $903M, down 11% from $1.02B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Sectoral Asset Management's Q4 2016 filing shows 11 new, 23 increased, 18 reduced and 12 closed positions. Its largest new stake was Biogen: 84,841 shares worth $24.1M. The largest sale was Medtronic, an estimated $45M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 94% a quarter earlier, followed by Financials.

  • Sectoral Asset Management's largest Q4 2016 buy was Biogen: 84,841 shares worth $24.1M.
  • Sectoral Asset Management added most to Acadia Pharmaceuticals in Q4 2016, an estimated $29.6M increase.
  • Sectoral Asset Management's biggest Q4 2016 reduction was Incyte, cutting an estimated $18.5M.
  • Sectoral Asset Management fully exited Medtronic in Q4 2016, selling an estimated $45M.
  • Sectoral Asset Management's ten largest holdings make up 47% of its $903M portfolio in Q4 2016.
  • Sectoral Asset Management opened 11 new positions and closed 12 in Q4 2016.
  • Sectoral Asset Management's portfolio value fell 11% quarter-over-quarter to $903M.

Based on Sectoral Asset Management's 13F filing for Q4 2016, filed 10 Feb 2017.